Dynavax Technologies Corporation (DVAX)
NASDAQ: DVAX · IEX Real-Time Price · USD
10.25
-0.17 (-1.63%)
At close: Jul 19, 2024, 4:00 PM
10.26
+0.01 (0.10%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Dynavax Technologies Revenue

Dynavax Technologies had revenue of $236.15M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $50.79M with 8.24% year-over-year growth. In the year 2023, Dynavax Technologies had annual revenue of $232.28M.

Revenue (ttm)
$236.15M
Revenue Growth
-63.98%
P/S Ratio
5.68
Revenue / Employee
$578,797
Employees
408
Market Cap
1.34B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023232.28M-490.40M-67.86%
Dec 31, 2022722.68M283.24M64.45%
Dec 31, 2021439.44M392.89M844.00%
Dec 31, 202046.55M11.33M32.18%
Dec 31, 201935.22M27.02M329.60%
Dec 31, 20188.20M7.87M2,407.03%
Dec 31, 2017327.00K-10.72M-97.04%
Dec 31, 201611.04M6.99M172.67%
Dec 31, 20154.05M-6.98M-63.29%
Dec 31, 201411.03M-219.00K-1.95%
Dec 31, 201311.25M1.54M15.82%
Dec 31, 20129.71M-11.90M-55.06%
Dec 31, 201121.61M-2.34M-9.75%
Dec 31, 201023.95M-16.37M-40.60%
Dec 31, 200940.32M3.22M8.69%
Dec 31, 200837.09M23.00M163.21%
Dec 31, 200714.09M9.25M190.76%
Dec 31, 20064.85M-9.81M-66.93%
Dec 31, 200514.66M-157.00K-1.06%
Dec 31, 200414.81M13.99M1,693.22%
Dec 31, 2003826.00K-601.00K-42.12%
Dec 31, 20021.43M-932.00K-39.51%
Dec 21, 20012.36M305.00K14.85%
Dec 31, 20002.05M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AdaptHealth 3.25B
U.S. Physical Therapy 611.97M
ANI Pharmaceuticals 517.46M
Phreesia 373.67M
Arcus Biosciences 237.00M
Vir Biotechnology 79.60M
Nurix Therapeutics 62.30M
Revenue Rankings